On Wednesday, Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s shares inclined 8.12% to $118.49.
Valeant Pharmaceuticals International, Inc. (VRX) declared updated financial guidance for the fourth quarter and full year 2015 in addition to new guidance for full year 2016.
Full Year 2016 Guidance
- Total Revenue $12.5 - $12.7 billion
- Adjusted EBITDA* $6.9 - $7.1 billion
- Adjusted non-GAAP EPS* $13.25 -$13.75
- Double Digit Same Store Sales Organic Growth - primarily driven through volume
- Expect to reduce debt by ~$2.25 billion , counting mandatory payments and maturities
- Expect net leverage ratio to be ~4.0 times pro forma adjusted EBITDA by the end of 2016
Q4 2015 Revised Guidance
- Total Revenues formerly $3.25 - $3.45 billion now $2.7 - $2.8 billion
- Adjusted EPS* formerly $4.00 - $4.20 now $2.55 -$2.65
- Adjusted Cash Flow from Operations* formerly greater than $1.0 billion , now greater than $600 million
Full Year 2015 Revised Guidance
- Total Revenue formerly $11.0 - $11.2 billion now $10.4 -$10.5 billion
- Adjusted EPS* formerly $11.67 - $11.87 now $10.23 -$10.33
- Adjusted Cash Flow from Operations* formerly greater than $3.35 billion , now greater than $2.95 billion
The company is hosting an Investor Day recently from 8:00 a.m. to 12:30 p.m. ET to talk about the updated and new financial guidance and provide an overview of select business operations and R&D programs.
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, in addition to Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer.
Comcast Corporation (NASDAQ:CMCSA)’s shares gained 1.65% to $58.70. The company’s total market capitalization is $141.56 billion along with 2.10 billion shares outstanding. 52 week range of the stock remained $50.01 - $64.99, while its day lowest price was $57.82 and its hit its day highest price at $58.87.
Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Cable Networks, Broadcast Television, Filmed Entertainment, and Theme Parks segments. The Cable Communications segment offers video, high-speed Internet, and voice services to residential and business customers under the XFINITY brand name.
At the end of Wednesday’s trade, Cameron International Corporation (NYSE:CAM)‘s shares dipped -0.54% to $64.20. CAM has beta value stands at 0.78 times and earnings per share were $1.04. The company has total of 190.92 million outstanding shares and its total market capitalization is $12.33 billion. 52-week price range of the stock remained $39.52 - $71.22.
Cameron International Corporation provides flow equipment products, systems, and services worldwide. The company’s Subsea segment offers integrated solutions, products, systems, and services to the subsea oil and gas market, counting integrated subsea production systems involving wellheads, subsea trees, manifolds and flowline connectors, and subsea processing systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.